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ABSTRACT. Objective: Few studies have explored the topography of 
antisocial behavior in a nationally representative sample of inhalant us-
ers. We examined (a) the lifetime prevalence of 20 childhood and adult 
antisocial behaviors in inhalant users with inhalant-use disorders (IUD+) 
and without IUDs (IUD−); (b) the nature and strength of associations 
between inhalant use, IUDs, and specifi c antisocial behaviors in multi-
variate analyses; and (c) the relationships between inhalant use, IUDs, 
and antisocial behaviors in a national sample of adults with antisocial 
personality disorder. Method: The National Epidemiologic Survey on 
Alcohol and Related Conditions was a multistage national survey of 
43,093 U.S. residents. Respondents completed a structured psychiatric 
interview. Results: IUD+ and IUD− respondents were signifi cantly 
younger and more likely to be unemployed, to be male, to have never 
married, and to report family and personal histories of alcohol and drug 
problems than inhalant nonusers. Family histories of alcohol problems 
and personal histories of drug problems were signifi cantly more preva-
lent among IUD+ respondents, compared with IUD− respondents. In 
bivariate analyses, IUD+ and IUD− respondents evidenced signifi cantly 
higher lifetime levels of all childhood and adult antisocial behaviors than 
inhalant nonusers. IUD+ respondents were signifi cantly more likely than 
their IUD− counterparts to report bullying behavior, starting physical 
fi ghts, using dangerous weapons, physical cruelty to people, staying 
out all night without permission, running away, and frequent truancy in 
childhood, as well as greater deceitfulness, impulsivity, irritability/ag-
gressiveness, recklessness, and irresponsibility in adulthood. Multivari-
ate analyses indicated that IUD+ respondents had a signifi cantly elevated 
risk for childhood and adult antisocial behaviors, compared with inhalant 
nonusers, with the strongest effects for using dangerous weapons, physi-
cal cruelty to animals, and physical cruelty to people. Similarly, IUD+ 
respondents differed signifi cantly from their IUD− counterparts primar-
ily across measures of interpersonal violence. Among persons with 
antisocial personality disorder, inhalant use and IUDs were associated 
with greater antisocial behavior, albeit with fewer and weaker effects. 
Conclusions: Respondents with IUDs had pervasively elevated levels 
of antisocial conduct, including diverse forms of early-onset and inter-
personally violent behavior. (J. Stud. Alcohol Drugs, 71, 201-209, 2010)
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CRIMINOLOGICAL AND CLINICAL STUDIES sug-gest that adolescent and adult inhalant users are dispro-
portionately involved in antisocial acts. Howard et al. (2008) 
found that 36.7% of 723 youths in residential treatment for 
antisocial behavior had used inhalants. Inhalant users dis-
played greater frequency of antisocial behavior in the prior 
year, earlier onset of offending, and more antisocial attitudes 
than inhalant nonusers. Howard and Jenson (1999) identifi ed 
lifetime inhalant use in 34.3% of 475 juvenile probationers. 
Inhalant users were signifi cantly more likely than nonusers 
to report intentions to engage in illegal behavior and more 
frequent participation in criminal behavior.
 Clinical investigations of adolescent inhalant users have 
yielded results consistent with those involving juvenile 
offenders. Sakai et al. (2004) assessed 847 adolescents 
admitted to a treatment program for youths with substance-
use and behavior disorders, identifying signifi cantly higher 
rates of conduct disorder in adolescent inhalant users and 
adolescents with inhalant-use disorders (IUDs), compared 
with inhalant nonusers. However, lifetime inhalant users 
with versus without Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV; 
American Psychiatric Association, 2000), IUDs did not dif-
fer signifi cantly with regard to the percentages diagnosed 
with conduct disorder, and fi ndings for specifi c antisocial 
behaviors were not reported. In a 2-year follow-up of 80 ado-
lescents completing chemical-dependency treatment, Sakai 
et al. (2006) reported that inhalant users exhibited twice as 
many conduct-disorder symptoms as inhalant nonusers. The 
relationship between inhalant use and the number of post-
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treatment conduct-disorder symptoms remained signifi cant in 
multivariate analyses, when the baseline number of lifetime 
conduct-disorder symptoms was controlled for.
 Few general-population surveys have examined asso-
ciations of inhalant use or IUDs with adolescent antisocial 
behavior. Siqueria and Crandall (2007) surveyed 60,345 
Floridian 6th-12th graders, reporting that inhalant users 
were signifi cantly more likely to be truant from school and 
to have parents with a history of antisocial behavior than 
inhalant nonusers. Wu et al. (2005) estimated that 9% of 
12- to 17-year-olds in the United States had used inhalants 
and found that inhalant users who had engaged in past-year 
delinquent behaviors were 5.9 times more likely to be diag-
nosed with past-year DSM-IV inhalant abuse, compared with 
inhalant users who had not engaged in past-year delinquent 
behaviors.
 Studies evaluating associations between inhalant use, 
IUDs, and specifi c adult antisocial behaviors are infrequently 
reported. Compton et al. (1994) identifi ed a signifi cant as-
sociation between inhalant use and antisocial personality 
disorder (ASPD) in a treatment sample of 545 St. Louis il-
licit drug users; 64% of lifetime inhalant users met DSM-IV 
ASPD criteria, compared with 35% of inhalant nonusers. Wu 
and Ringwalt (2006) reported that 2.6% of total respondents 
to the 2002/2003 National Survey on Drug Use and Health 
had been booked or arrested in the prior year, compared with 
49.9% of lifetime inhalant users.
 Using data from the National Epidemiologic Survey on 
Alcohol and Related Conditions (NESARC), the largest na-
tionally representative comorbidity survey ever conducted, 
Wu and Howard (2007) identifi ed signifi cantly elevated prev-
alence rates for ASPD among men (36%) and women (22%) 
who had used inhalants. Compton et al. (2005) reported that 
NESARC respondents meeting DSM-IV criteria for inhalant 
abuse were 18.7 times more likely to meet DSM-IV ASPD 
criteria than respondents without inhalant abuse, and that the 
strength of this association exceeded that between any other 
type of DSM-IV substance abuse and ASPD.
 Antisocial behaviors occurring among persons with 
substance-use disorders are clinically important. Goldstein 
et al. demonstrated that antisocial behavior syndromes, 
particularly those occurring in adulthood, are associated 
with increased severity of substance-use disorders (e.g., 
Goldstein et al., 2006, 2007). These researchers concluded 
that childhood antisocial behavior portended greater severity 
of substance-use disorders in adulthood, primarily for those 
respondents who continued clinically signifi cant childhood 
antisocial behavior into adulthood.
 Although fi ndings suggest that inhalant use commonly co-
occurs with antisocial conduct, many issues relevant to this 
association remain unresolved. Studies have rarely assessed 
the prevalence of specifi c antisocial behaviors occurring 
across the life course or examined whether childhood and 
adult antisocial behaviors relate differentially to inhalant 
use/IUDs. Greater knowledge of the specifi c types and pat-
terns of antisocial conduct associated with inhalant use/IUDs 
could enhance screening, prevention, and treatment interven-
tions targeting inhalant users by identifying the types and 
optimal locations of services required for this population.
 The present investigation also examined whether the 
prevalence of antisocial behavior increased monotonically 
with greater levels of problematic involvement with inhal-
ants. A key strength of the reported fi ndings is that they are 
based on results of a large, nationally representative survey; 
thus, inferential errors deriving from studies of comorbidity 
in selected samples of inhalant users are minimized.
 Available NESARC data allowed our group to address 
current gaps in the literature pertaining to inhalant use, 
IUDs, and antisocial behavior. We examined (a) the com-
parative prevalence of 20 childhood and adult antisocial 
behaviors in inhalant nonusers and lifetime inhalant users 
with (IUD+) and without (IUD−) lifetime IUDs; (b) the na-
ture and strength of associations between inhalant use, IUDs, 
and childhood and adult antisocial behaviors in controlled 
multivariate analyses; and (c) associations between inhalant 
use, IUDs, and childhood and adult antisocial behaviors in 
adults with ASPD.
 We hypothesized that IUD+ respondents would have 
a signifi cantly greater prevalence of childhood and adult 
antisocial behaviors, compared with their IUD− counter-
parts, and that IUD− respondents would, in turn, evidence 
signifi cantly more prevalent childhood and adult antisocial 
behaviors than inhalant nonusers. We further hypothesized 
that these relationships would be most pronounced for se-
verely antisocial behaviors such as interpersonal violence 
and would be observed even within a national sample with 
signifi cantly restricted range for antisocial behavior, includ-
ing only respondents with ASPD.
Method
Subjects, sampling, and interviews
 Study fi ndings are based on data from the 2001-2002 
NESARC. NESARC includes a representative sample of 
43,093 U.S. adults (Grant et al., 2003). The survey gathered 
information on substance-use disorders and comorbid con-
ditions from individuals living in households and group set-
tings. NESARC used a multistage sampling design and had 
a response rate of 81%. Data were weighted at the individual 
and household levels and were adjusted for oversampling, for 
nonresponse, and to be representative of the U.S. population 
as assessed by the 2000 census.
 U.S. Census Bureau workers administered the Alcohol 
Use Disorders and Associated Disabilities Interview Sched-
ule–IV (AUDADIS-IV; Grant et al., 2003). AUDADIS is 
a structured interview designed for administration by lay 
interviewers. AUDADIS-IV reliably assesses DSM-IV 
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substance-use disorders (Grant et al., 2003). The NESARC 
survey, sampling protocol, and codebook are available at 
http://niaaa.census.gov.
Measurement
 Inhalant use and inhalant-use disorders. Inhalant users 
were those respondents who answered affi rmatively to the 
question “Have you ever used inhalants or solvents, for 
example, amyl nitrite, nitrous oxide, glue, toluene, or gaso-
line?” An introductory statement informed the respondents 
that they were to report inhalants used on their own, without 
a doctor’s prescription, and for the purposes of getting high, 
enjoying themselves, relaxing, feeling better, feeling more 
alert, or quieting their nerves or to see how the inhalants 
would work. Inhalant-abuse diagnoses were assigned to 
inhalant users who met DSM-IV inhalant-abuse criteria but 
who did not meet inhalant-dependence criteria; inhalant-
dependence diagnoses were assigned to subjects who met 
DSM-IV inhalant-dependence criteria. Respondents were 
classifi ed as inhalant nonusers if they reported no lifetime 
inhalant use, were classifi ed as inhalant users without IUDs 
(IUD−) if they reported inhalant use but had never met 
DSM-IV inhalant-abuse or inhalant-dependence criteria, or 
were classifi ed as inhalant users with IUDs (IUD+) if they 
reported inhalant use and met lifetime criteria for either 
inhalant abuse or dependence.
 Childhood and adult antisocial behaviors/antisocial 
personality disorder. NESARC respondents answered 59 
questions assessing 20 DSM-IV conduct disorder and ASPD 
diagnostic criteria. Questions assessing conduct-disorder 
criteria evaluated the presence versus the absence of the 
following childhood/adolescent behaviors: bullying, threaten-
ing, or intimidation; starting physical fi ghts; using dangerous 
weapons; physical cruelty to people; physical cruelty to ani-
mals; stealing with confrontation; forcing someone to have 
sex; deliberate fi re setting; deliberate vandalism; frequent 
lying for secondary gain; stealing without confrontation; 
staying out all night without permission; running away at 
least twice or once without returning; and frequent truancy. 
Questions assessing ASPD criteria evaluated the presence 
versus the absence of the following adult behaviors: failure 
to conform to social norms with respect to lawful behaviors 
(i.e., repeatedly performing acts that are grounds for arrest); 
deceitfulness (i.e., repeated lying, use of aliases, or conning 
others for personal profi t or pleasure); impulsivity or failure 
to plan ahead; irritability and aggressiveness (i.e., repeated 
physical fi ghts or assaults); reckless disregard for the safety 
of self or others; and consistent irresponsibility. Respondents 
were assigned an ASPD diagnosis per DSM-IV guidelines.
 Covariates. Lifetime alcohol-use disorder diagnoses 
(abuse or dependence) and noninhalant drug-use disorder 
diagnoses (abuse or dependence on heroin, hallucinogens, 
cocaine/crack, marijuana, stimulants, painkillers, tranquil-
izers, and sedatives) were assigned per DSM-IV guidelines. 
Response categories for region of residence in United States; 
race; gender; age; marital, educational, and unemployment 
status; and annual family income are listed in Table 1. 
Family histories of alcohol, drug, and antisocial behavior 
problems, respectively, were recorded as present or absent, 
based on the respondents’ answers to questions assessing 
whether their “blood or natural father” or “blood or natural 
mother” had ever “been an alcoholic or problem drinker,” 
had “problems with drugs,” or had “behavior problems.” A 
respondent reporting a paternal and/or maternal history of 
a given problem was regarded as having a family history of 
that problem.
Analytic plan
 Weighted prevalence estimates and 95% confi dence inter-
vals were computed using SUDAAN Version 9.0 (Research 
Triangle Institute, 2004). SUDAAN implements a Taylor 
series linearization to adjust standard errors of estimates for 
complex survey sampling design effects involving clustered 
data. Multivariate logistic regression analyses were conduct-
ed via simultaneous entry of the following covariates: sex, 
age, marital status, education (in years), employment status, 
annual family income, region of the United States, lifetime 
history of a DSM-IV alcohol-use disorder, lifetime history of 
a DSM-IV noninhalant drug-use disorder, family history of 
antisocial behavior, family history of alcohol problems, and 
family history of drug problems. Adjusted odds ratios (ORs) 
and 95% confi dence intervals (CIs) are presented to refl ect 
association strength and signifi cance.
Results
Characteristics of inhalant users
 IUD+ and IUD− respondents were younger and reported 
more prevalent family and personal histories of alcohol- 
and drug-use problems than inhalant nonusers. Larger 
proportions were White, men, never married, and currently 
unemployed, relative to inhalant nonusers. IUD+ and IUD− 
inhalant users differed signifi cantly only with regard to 
family history of alcohol problems and a lifetime personal 
history of noninhalant drug-use disorder. Most (93.3%) re-
spondents with IUDs met criteria for at least one additional 
drug-use disorder, and a majority (62.0%) reported a family 
history of alcohol problems.
Prevalence of antisocial behaviors among inhalant users in 
the general population
 Childhood antisocial behaviors. Signifi cant differences 
were observed between inhalant user (i.e., IUD+/IUD−) and 
nonuser groups for 12 of 14 childhood antisocial behaviors. 
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TaBLe 1.    Demographic, family history, and clinical characteristics of NESARC respon-
dents, by lifetime inhalant use status (N = 41,594)*
   Inhalant 
 IUD+ IUD− nonusers 
Respondent characteristics (n = 132) (n = 509) (n = 40,953)
Sex, male 76.7a 72.5b 47.2a,b
Age, in years a b a,b
 18-34 48.9 52.3 31.3
 35-54 47.3 43.5 39.8
 ≥55 3.9 4.2 28.9
Race, white 79.0 82.6a 70.8a
Marital status a b a,b
 Married/cohabitating 40.2 45.0 62.3
 Divorced/separated, widowed 17.6 16.4 17.3
 Never married 42.2 38.6 20.4
Education
 <High school 21.0 11.4 15.5
 High school 29.7 26.7 29.4
 >High school 49.4 62.0 55.1
Currently unemployed 20.5a 22.8b 8.5a,b
Annual family income, U.S. $
 0-19,999 32.5 26.8 23.3
 20,000-34,999 19.2 18.6 20.1
 35,000-69,999 31.3 32.5 32.2
 ≥70,000 16.9 22.1 24.3
Region of United States  a a
 Northeast 18.5 22.9 19.7
 Midwest 22.4 20.7 23.2
 South 33.1 23.2 35.3
 West 25.9 33.4 21.8
Family history of antisocial behavior 31.7a 24.1b 8.7a,b
Family history of alcohol problems 62.0a,b 47.4a,c 22.0b,c
Family history of drug problems 22.4a 16.0b 3.7a,b
Lifetime personal history of DSM-IV
 alcohol-use disorder 90.1a 86.7b 29.3a,b
Lifetime personal history of DSM-IV
 noninhalant drug-use disorder 93.3a,b 74.2b,c 9.2a,c
Notes: *Chi-square tests were used for overall comparisons, with adjustments for multiple 
comparisons. Where differences were observed (α = .004), post hoc contrasts were conduct-
ed to identify specific group differences; groups with shared superscripts are significantly 
different from one another. Cell totals may not equal 100% because of rounding. NESARC 
= National Epidemiologic Survey on Alcohol and Related Conditions; DSM-IV = Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition; IUD+ = inhalant users with 
DSM-IV inhalant-use disorders; IUD− = lifetime inhalant users without DSM-IV inhalant-
use disorders; inhalant nonusers had no lifetime inhalant use. All ns in column headings are 
unweighted values; table values are weighted column percentages (SEs).
Lifetime prevalence rates of antisocial behaviors, in relative 
terms, were low in inhalant nonusers, intermediate in IUD− 
users, and high in IUD+ respondents (Table 2).
 Half of all bivariate comparisons of IUD+ versus IUD− 
respondents were statistically significant; the largest absolute 
differences in prevalence rates were for physical cruelty to 
people, frequent truancy, and starting physical fights. IUD+ 
respondents evidenced more prevalent antisocial behavior 
than inhalant nonusers across all measures; the largest 
absolute differences were for nonconfrontational stealing, 
truancy, bullying, and physical cruelty to people. IUD− re-
spondents reported significantly greater prevalence rates for 
antisocial behavior than inhalant nonusers across all mea-
sures; the largest differences were for nonconfrontational 
stealing, vandalism, and bullying.
 Adult antisocial behaviors. Adult antisocial behaviors 
were reported by two thirds to more than four fifths of IUD+ 
respondents, compared with approximately one half to three 
quarters of IUD− respondents and one tenth to one fifth of 
inhalant nonusers.
 Differences between IUD+ respondents and inhalant non-
users were large and statistically significant, ranging from 
42.5% to 65.6% across antisocial behaviors. Differences be-
tween IUD− and inhalant-nonuser prevalence rates for adult 
antisocial behaviors ranged from 24.9% to 60.5% and were 
statistically significant. Four of six contrasts between IUD+ 
and IUD− respondents were statistically significant.
Antisocial behaviors among inhalant users/nonusers with 
antisocial personality disorder
 Childhood antisocial behaviors. A subsample including 
all respondents with ASPD (3.3%, n = 1,380) was drawn 
from the total NESARC sample. Prevalence rates for child-
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TaBLe 2.    Prevalence of childhood and adult antisocial behaviors in the total NESARC sample and subsample of respondents with antisocial personality 
disorder, by lifetime inhalant use/inhalant-use disorder status*
 Total sample Antisocial personality disorder subsample
    Inhalant    Inhalant 
 Overall IUD+ IUD− nonusers Overall IUD+ IUD− nonusers 
Behavior (N = 41,364) (n = 128) (n = 505) (n = 40,731) (N = 1,380) (n = 132) (n = 61) (n = 1,187)
Childhood antisocial behaviors
 Bullying/threatening/intimidation 4.3 30.0a,b 18.2b,c 4.0a,c 46.5 55.3 45.4 46.2
   (0.16) (4.62) (2.14) (0.15) (1.68) (7.38) (5.82) (1.82)
 Starting physical fights 2.9 23.4a,b 9.9b,c 2.7a,c 35.2 40.8 28.0 35.8
   (0.12) (5.01) (1.59) (0.11) (1.57) (7.91) (4.52) (1.61)
 Using dangerous weapons 0.9 12.0a,b 2.7b,c 0.8a,c 14.1 25.2 9.6 14.1
   (0.06) (3.61) (0.75) (0.06) (1.19) (6.75) (2.57) (1.30)
 Physical cruelty to people 3.3 28.3a,b 12.2b,c 3.0a,c 37.5 52.2 30.6 37.6
   (0.13) (4.74) (1.80) (0.12) (1.74) (7.21) (4.74) (1.90)
 Physical cruelty to animals 1.3 13.0a 7.5a 1.1a,b 14.6 24.2 15.3 14.0
   (0.07) (3.74) (1.21) (0.07) (1.14) (6.58) (3.46) (1.19)
 Stealing with confrontation** 0.1 4.9 0.4 0.1 1.7 10.4 1.4 1.3
   (0.02) (2.75) (0.27) (0.01) (0.38) (5.47) (0.96) (0.32)
 Forcing someone into sex** 0.0 0.9 0.6 0.0 0.2 1.0 1.0 0.1
   (0.01) (0.62) (0.39) (0.01) (0.13) (0.95) (1.00) (0.08)
 Deliberate fire setting 0.9 9.4a 7.8b 0.7a,b 12.7 18.5 25.4 10.8
   (0.06) (2.79) (1.88) (0.06) (1.19) (5.57) (5.65) (1.13)
 Deliberate vandalism 1.8 19.9a 16.4b 1.5a,b 32.3 39.7 48.4 29.8
   (0.10) (4.27) (2.37) (0.09) (1.55) (7.33) (6.01) (1.51)
 Frequent lying for secondary gain 3.2 25.6a 16.9b 3.0a,b 42.5 46.5 50.5 41.3
   (0.12) (4.91) (1.97) (0.11) (1.60) (7.63) (4.97) (1.79)
 Nonconfrontational stealing 11.8 56.2a 53.7b 11.0a,b 75.6 83.7 92.7a 73.0a
   (0.38) (5.26) (2.58) (0.35) (1.40) (5.62) (2.53) (1.54)
 Staying out all night without 2.6 23.1a,b 10.7b,c 2.4a,c 28.2 47.3 29.8 27.0
  parental permission (0.12) (4.73) (1.65) (0.11) (1.53) (7.80) (4.55) (1.58)
 Running away at least twice or 2.6 22.8a,b 12.6b,c 2.4a,c 30.3 38.1 34.4 29.3
  once without returning (0.12) (4.58) (1.78) (0.11) (1.48) (7.18) (4.80) (1.59)
 Frequent truancy 3.0 29.2a,b 14.8b,c 2.8a,c 30.6 56.5 32.0 29.1
   (0.12) (4.60) (1.89) (0.11) (1.41) (7.09) (5.22) (1.53)
Adult antisocial behaviors
 Repeated unlawful behaviors 17.3 81.9a 76.8b 16.3a,b 82.3 91.0a 92.7b 80.a,b
   (0.49) (4.06) (2.49) (0.46) (1.19) (4.38) (3.02) (1.371)
 Deceitfulness 5.9 47.9a,b 30.3b,c 5.4a,c 48.7 61.6 56.7 47.1
   (0.17) (5.37) (2.42) (0.15) (1.72) (7.32) (5.60) (1.76)
 Impulsivity/failure to plan ahead 20.8 72.4a,b 55.6b,c 20.2a,c 72.9 87.9 75.2 71.8
   (0.46) (4.11) (2.72) (0.45) (1.52) (4.46) (4.67) (1.66)
 Irritability/aggressiveness 14.2 69.7a,b 46.1b,c 13.6a,c 77.4 89.6 72.4 77.5
   (0.37) (4.77) (2.64) (0.35) (1.45) (4.41) (5.16) (1.55)
 Recklessness 22.1 76.6a 66.9b 21.3a,b 71.1 83.7 82.1 69.1
   (0.67) (4.32) (2.56) (0.65) (1.63) (5.88) (5.13) (1.80)
 Consistent irresponsibility 16.6 68.0a,b 53.0b,c 15.9a,c 67.6 82.4 70.1 66.6
   (0.35) (4.65) (2.82) (0.33) (1.58) (5.53) (4.82) (1.74)
Notes: Chi-square tests were used for overall comparisons, with adjustments for multiple comparisons. Where differences were observed (α = .0025), post hoc 
contrasts were conducted to identify specific group differences; groups with shared superscripts are significantly different. NESARC = National Epidemiologic 
Survey on Alcohol and Related Conditions; IUD+ = inhalant users with Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV), 
inhalant-use disorders; IUD− = lifetime inhalant users without lifetime DSM-IV inhalant-use disorders; inhalant nonusers reported no lifetime inhalant use. 
*Values are column percentages (SEs) unless otherwise specified; **test statistic was not reported because of low cell counts.
hood antisocial behaviors were higher for IUD+ respondents, 
compared with inhalant nonusers, in all cases. For 10 of 14 
contrasts, prevalence rates for childhood antisocial behaviors 
were lower among inhalant nonusers than among IUD− re-
spondents. However, only the contrast for nonconfrontational 
stealing was statistically significant at the Bonferroni-adjust-
ed p value.
 The largest absolute differences in lifetime prevalence 
rates between IUD+ and IUD− respondents with ASPD were 
for frequent truancy, physical cruelty to people, staying out 
all night, using dangerous weapons, and starting physical 
fights. Absolute differences between IUD+ and inhalant 
nonusers were generally modest but were largest for frequent 
truancy, staying out all night, and physical cruelty to people. 
The largest absolute differences for IUD− versus inhalant 
nonuser comparisons were for nonconfrontational stealing, 
vandalism, and fire setting.
 Adult antisocial behaviors. Group differences were ob-
served for repeated unlawful behaviors at the Bonferroni-ad-
justed p value of .0025, where IUD+ and IUD− respondents 
206 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / MARCH 2010
had the highest rates of this behavior. For all other ASPD 
indicators, trends were observed where IUD+ respondents 
had the highest rates of antisocial behavior; inhalant non-
users reported the lowest rates of antisocial behavior. The 
largest differences in absolute terms for IUD+ versus IUD− 
contrasts were for irritability/aggressiveness, impulsivity, 
and consistent irresponsibility; only the contrast for irritabil-
ity/aggressiveness was statistically signifi cant. IUD+ versus 
inhalant nonuser differences in prevalence rates ranged from 
10.5% (repeated unlawful behaviors) to 16.1% (impulsiv-
ity); all such contrasts were statistically signifi cant except 
that for deceitfulness. Differences between IUD− and in-
halant nonuser groups generally were not large. It should 
be noted, however, that these trends were not statistically 
signifi cant.
Multivariate logistic regression analyses of inhalant use, 
inhalant-use disorders, and childhood and adult antisocial 
behaviors
 Total NESARC sample. Multivariate logistic regression 
analyses with simultaneous entry of covariates (see Method 
section for a listing) were conducted across each antisocial 
behavior measure. In the total NESARC sample, 10 of 12 
ORs for comparisons of IUD+ adults versus inhalant nonus-
ers across childhood antisocial behaviors and 8 of 12 such 
ORs for IUD− respondents versus inhalant nonusers were 
statistically signifi cant. These results indicated that inhalant 
users were signifi cantly more likely to engage in most child-
hood antisocial behaviors than nonusers.
 For 10 of 12 childhood antisocial behaviors, differences 
with inhalant nonusers were larger for IUD+ than IUD− 
adults. The largest ORs for IUD+ versus inhalant nonuser 
contrasts were for interpersonally violent behaviors, includ-
ing using dangerous weapons, physical cruelty to animals, 
and physical cruelty to people. The largest ORs for IUD− 
versus inhalant nonuser contrasts were for nonconfronta-
tional stealing and fi re setting.
 IUD+ respondents were signifi cantly more likely than 
inhalant nonusers to evidence fi ve of six adult antisocial 
behaviors. Likewise, ORs were statistically signifi cant for 
fi ve of six IUD− versus inhalant nonuser group contrasts 
for adult antisocial behaviors. For fi ve of six adult antisocial 
behavior group contrasts, ORs for comparisons with inhal-
ant nonusers were larger for IUD+ than for IUD− adults. 
Even with the extensive set of covariates employed, IUD+ 
respondents were 1.8 to 2.9 times and IUD− respondents 
were 1.2 to 2.9 times more likely than inhalant nonusers 
to report adult antisocial behaviors. The largest effects for 
IUD+ respondents versus inhalant nonusers were for de-
ceitfulness, irritability/aggressiveness, and impulsivity. The 
largest effects for IUD− versus inhalant nonusers were for 
repeated unlawful behaviors, consistent irresponsibility, and 
deceitfulness.
 Whereas the fi ndings in Table 3 present comparisons of 
IUD+ and IUD- respondents with inhalant nonusers, direct 
comparisons of IUD+ and IUD− respondents in controlled 
multivariate logistic regressions indicated that IUD+ respon-
dents were signifi cantly more likely than IUD– respondents 
to report physical cruelty to people (OR = 2.85, 95% CI [1.3, 
6.1]) and using dangerous weapons (OR = 4.8, 95% CI [1.6, 
14.2]) in childhood, and irritability/aggressiveness (OR = 
2.2, 95% CI [1.24, 4.1]) and impulsivity (OR = 1.92, 95% 
CI [1.1, 3.5]) in adulthood.
 Antisocial personality disorder subsample. Within the 
subsample of respondents meeting ASPD criteria, 3 of 12 
IUD+ versus inhalant-nonuser group contrasts were signifi -
cant for childhood antisocial behaviors. IUD+ respondents 
exhibited higher levels of physical cruelty to people, truancy, 
and staying out all night than inhalant nonusers. Two of 12 
IUD– versus inhalant-nonuser group contrasts for childhood 
antisocial behaviors were statistically signifi cant. IUD− re-
spondents were more likely to report stealing without con-
frontation and illegal fi re setting, compared with inhalant 
nonusers. None of the six IUD+ versus inhalant nonuser or 
six IUD− versus inhalant-nonuser group contrasts was sta-
tistically signifi cant for adult antisocial behaviors. However, 
the OR for the IUD+ versus the inhalant-nonuser group 
comparison was elevated at 3.1 (95% CI [0.75, 12.6]) for 
irritability/aggressiveness.
 Direct comparisons of IUD+ versus IUD− respondents 
with ASPD indicated that IUD+ respondents were signifi -
cantly more likely to report physical cruelty to people (OR = 
3.2, 95% CI [1.2, 8.6]), using dangerous weapons (OR = 3.1, 
95% CI [1.0, 9.1]), and frequent truancy (OR = 3.2, 95% CI 
[1.2, 8.6]) in childhood, and they did not differ signifi cantly 
from IUD− respondents across any adult antisocial behavior, 
although the difference for irritability/aggressiveness ap-
proached signifi cance (OR = 3.8, 95% CI [0.90, 15.8]).
Discussion
Summary of fi ndings
 Inhalant users were signifi cantly younger, and larger 
percentages were men, White, unmarried, and unemployed 
and had family histories of alcohol problems, drug problems, 
and antisocial behavior problems and personal histories of 
alcohol and noninhalant drug-use problems, compared with 
inhalant nonusers. Signifi cantly larger percentages of IUD+ 
respondents reported family histories of alcohol problems 
and personal histories of DSM-IV noninhalant drug-use 
disorders, compared with IUD− respondents.
 Lifetime prevalence rates for childhood antisocial behav-
ior were high in IUD+ respondents (>20% for eight behav-
iors), compared with those for inhalant nonusers (>5% for 
only one behavior); rates of IUD− respondents were inter-
mediate to those of IUD+ respondents and inhalant nonusers. 
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TABLE 3.    Adjusted odds of childhood and adult antisocial behaviors in lifetime inhalant users with (IUD+) and without 
(IUD−) lifetime IUDs compared with inhalant nonusers, in the total NESARC sample and the subsample of respondents with 
antisocial personality disorder*
  Antisocial personality
 Total sample disorder subsample
 (N = 37,048) (n = 1,119)
Antisocial behaviors AOR [95% CI] AOR [95% CI]
Childhood antisocial behaviors
 Bullying/threatening/intimidation
  IUD+ 2.47 [1.37, 4.47] 1.81 [0.77, 4.22]
  IUD− 1.72 [1.22, 2.42] 1.18 [0.66, 2.10]
 Starting physical fi ghts
  IUD+ 2.63 [1.26, 5.46] 1.06 [0.48, 2.36]
  IUD− 1.25 [0.84, 1.88] 0.90 [0.56, 1.44]
 Using dangerous weapons
  IUD+ 4.03 [1.55, 10.50] 2.48 [0.93, 6.63]
  IUD− 0.84 [0.41, 1.74] 0.68 [0.32, 1.45]
 Physical cruelty to people
  IUD+ 3.42 [1.71, 6.83] 2.79 [1.20, 6.51]
  IUD− 1.20 [0.80, 1.81] 0.87 [0.51, 1.51]
 Physical cruelty to animals
  IUD+ 3.71 [1.56, 8.82] 2.15 [0.78, 5.88]
  IUD− 1.93 [1.18, 3.14] 0.70 [0.31, 1.56]
 Stealing with confrontation
  IUD+ ** ** ** **
  IUD−
 Forcing someone into sex
  IUD+ ** ** ** **
  IUD−
 Deliberate fi re setting
  IUD+ 2.11 [0.85, 5.22] 1.25 [0.39, 3.95]
  IUD− 2.69 [1.61, 4.48] 2.29 [1.27, 4.12]
 Deliberate vandalism
  IUD+ 2.64 [1.30, 5.36] 1.17 [0.53, 2.56]
  IUD− 2.46 [1.59, 3.80] 1.41 [0.78, 2.52]
 Frequent lying for secondary gain
  IUD+ 1.52 [0.72, 3.21] 0.80 [0.34, 1.88]
  IUD− 1.47 [1.00, 2.17] 1.23 [0.71, 2.13]
 Nonconfrontational stealing
  IUD+ 2.04 [1.12, 3.69] 1.87 [0.64, 5.45]
  IUD− 2.72 [2.12, 3.50] 3.51 [1.47, 8.38]
 Staying out all night without
 parental permission
  IUD+ 3.32 [1.68, 6.56] 2.27 [0.99, 5.20]
  IUD− 1.63 [1.02, 2.61] 1.19 [0.68, 2.07]
 Running away at least twice,
 or once without returning
  IUD+ 2.75 [1.29, 5.84] 1.69 [0.69, 4.11]
  IUD− 2.02 [1.27, 3.20] 1.67 [0.97, 2.89]
 Frequent truancy
  IUD+ 3.17 [1.67, 6.00] 3.50 [1.53, 8.01]
  IUD− 1.79 [1.22, 2.62] 1.08 [0.64, 1.82]
Adult antisocial behaviors
 Repeated unlawful behaviors
  IUD+ 2.25 [1.10, 4.61] 2.30 [0.41, 13.00]
  IUD− 2.86 [2.01, 4.05] 1.45 [0.62, 3.37]
 Deceitfulness
  IUD+ 2.88 [1.63, 5.08] 1.13 [0.49, 2.61]
  IUD− 1.60 [1.18, 2.17] 1.18 [0.71, 1.97]
 Impulsivity/failure to plan ahead
  IUD+ 2.63 [1.59, 4.35] 1.41 [0.55, 3.59]
  IUD− 1.37 [1.02, 1.84] 0.86 [0.46, 1.61]
 Irritability/aggressiveness
  IUD+ 2.64 [1.49, 4.67] 3.08 [0.75, 12.57]
  IUD− 1.18 [0.90, 1.53] 0.82 [0.47, 1.43]
 Recklessness
  IUD+ 1.81 [0.98, 3.34] 1.81 [0.55, 5.98]
  IUD− 1.45 [1.09, 1.93] 1.05 [0.49, 2.26]
 Consistent irresponsibility
  IUD+ 2.46 [1.50, 4.03] 1.44 [0.58, 3.58]
  IUD− 1.65 [1.24, 2.18] 1.07 [0.59, 1.95]
Notes: *Inhalant nonusers were the reference group. Each model adjusted for sex; current age; marital status; education; em-
ployment status; annual family income; region of the United States; lifetime history of Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV), alcohol-use disorder and lifetime history of a noninhalant drug-use disorder; and 
family history of antisocial behavior, alcohol problems, and drug problems. Values in bold are statistically signifi cant based on 
a 95% confi dence interval [CI] that does not bound 1.0. IUD+ = inhalant users with lifetime DSM-IV inhalant use-disorders; 
IUD− = lifetime inhalant users without lifetime DSM-IV inhalant-use disorders; inhalant nonusers had no lifetime inhalant 
use; NESARC = National Epidemiologic Survey on Alcohol and Related Conditions; AOR = adjusted odds ratio; **AORs 
were not reported because of small cell count.
208 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / MARCH 2010
way of evidence-based prevention or treatment interventions 
for IUDs. Therefore, early identifi cation of youth at risk for 
inhalant use and IUDs might provide practitioners with a 
better opportunity to help prevent or ameliorate the serious 
harm associated with repeated use of these toxic agents.
Limitations
 The results reported here are based on self-report data 
and are subject to possible unreliable recall and/or social-
desirability bias. Furthermore, the use of a single omnibus 
inhalant-assessment question may have underestimated the 
actual level of inhalant use and may have captured a hetero-
geneous group of inhalant users that included respondents 
(e.g., nitrite users) who are not considered inhalant users 
under the current DSM-IV nosology. Rates of nitrite use, 
however, are very low nationally, and current fi ndings are 
consistent with recent reports documenting high levels 
of psychiatric (Wu and Howard, 2007) and substance-use 
(Wu et al., 2008) disorders, suicidal ideation and attempts 
(Freedenthal et al., 2007), and other deleterious health and 
social conditions (Howard et al., 2008) in inhalant users and 
persons with IUDs.
 A notable strength of this study, however, is that it exam-
ined the prevalence and correlates of specifi c childhood and 
adult antisocial behaviors in a large, nationally representative 
sample of lifetime inhalant users and persons with IUDs 
(assessed via structured psychiatric interviews), and it is the 
fi rst to have assessed the associations of inhalant use and 
IUDs with specifi c antisocial behaviors in a national sample 
of persons with ASPD. Further etiological and epidemiologi-
cal research is needed to inform nascent and ongoing efforts 
to prevent, detect, and treat IUDs in adolescents and adults at 
elevated risk for the development of these specifi c antisocial 
behaviors.
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